Insider Trading activities of Array Biopharma Inc (ARRY)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Array Biopharma Inc (ARRY) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Array Biopharma Inc since year 2005. Table 2 shows the detailed insider transactions of Array Biopharma Inc since 2005. The reporting company's ticker symbol is ARRY. The reporting company's CIK number is 1100412.
The total value of stock buying since 2005 is $24,290,234.
The total value of stock sales since 2005 is $101,889,471.
The total value of stock option exercises since 2005 is $22,444,270.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Array Biopharma Inc (ARRY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 0 $0 136,134 $3,847,756 136,134 $861,889
2019-05 0 $0 143,877 $3,866,190 115,728 $422,406
2019-04 0 $0 0 $0 86,877 $0
2019-02 5,000 $116,000 708,602 $14,854,352 572,264 $2,812,925
2019-01 0 $0 248,438 $4,558,135 354,774 $2,001,220
2018-12 0 $0 121,453 $1,955,123 257,087 $464,999
2018-11 3,000 $50,594 0 $0 0 $0
2018-10 0 $0 0 $0 30,000 $0
2018-09 0 $0 27,687 $414,617 18,000 $107,100
2018-08 0 $0 41,500 $577,680 21,500 $124,162
2018-07 0 $0 96,500 $1,600,290 123,025 $586,596
2018-06 0 $0 323,717 $5,900,039 400,967 $1,427,349
2018-05 0 $0 21,500 $330,261 21,500 $88,472
2018-04 0 $0 30,189 $459,961 64,937 $79,335
2018-03 0 $0 177,516 $3,123,383 203,691 $738,957
2018-02 0 $0 121,500 $2,064,439 121,500 $576,422
2018-01 0 $0 29,000 $381,185 35,525 $98,024
2017-12 0 $0 1,102,545 $11,936,724 1,355,900 $6,619,460
2017-10 0 $0 0 $0 25,000 $261,750
2017-09 0 $0 78,793 $971,938 90,000 $952,200
2017-08 0 $0 0 $0 20,000 $75,400
2017-04 0 $0 0 $0 50,154 $0
2017-03 0 $0 70,000 $633,150 70,000 $277,875
2016-10 0 $0 0 $0 25,000 $145,750
2016-09 400,000 $1,403,720 2,892,578 $17,253,088 95,890 $353,834
2016-01 1,300,000 $4,621,500 0 $0 0 $0
2015-10 100,140 $450,630 0 $0 0 $0
2015-09 682,452 $3,132,050 0 $0 95,891 $496,715
2015-08 2,421,393 $13,736,806 0 $0 0 $0
2015-05 0 $0 25,000 $184,475 25,000 $96,500
2015-03 0 $0 131,576 $1,068,072 243,202 $1,572,584
2013-11 0 $0 11,866 $68,704 0 $0
2013-09 0 $0 3,376,186 $20,260,308 0 $0
2013-08 0 $0 75,384 $529,086 70,625 $210,067
2013-07 0 $0 5,000 $32,500 68,723 $252,659
2013-04 0 $0 0 $0 20,000 $54,800
2012-10 0 $0 28,547 $162,318 0 $0
2012-02 0 $0 1,545 $4,094 0 $0
2012-01 0 $0 1,994 $4,107 0 $0
2011-12 119,600 $246,468 1,743 $4,096 0 $0
2011-11 64,253 $142,063 1,656 $4,090 0 $0
2011-10 0 $0 1,977 $4,112 0 $0
2011-09 0 $0 2,034 $4,108 0 $0
2011-08 5,000 $11,100 4,110 $9,012 0 $0
2011-07 0 $0 1,638 $4,095 0 $0
2011-06 25,000 $54,250 1,720 $4,093 0 $0
2011-05 20,000 $57,200 1,484 $4,081 0 $0
2011-04 0 $0 1,696 $5,247 0 $0
2011-03 0 $0 1,310 $4,074 0 $0
2011-02 0 $0 1,403 $4,082 0 $0
2011-01 0 $0 28,270 $91,959 0 $0
2010-12 0 $0 1,256 $4,069 0 $0
2010-11 0 $0 11,220 $36,792 0 $0
2010-10 0 $0 21,292 $70,087 0 $0
2010-09 0 $0 1,415 $4,075 0 $0
2010-08 0 $0 6,336 $20,583 0 $0
2010-07 0 $0 1,309 $4,070 0 $0
2010-06 0 $0 2,858 $9,218 33,789 $20,273
2010-05 4,000 $14,840 1,183 $4,069 0 $0
2010-04 0 $0 1,074 $4,059 0 $0
2010-03 0 $0 1,661 $4,086 0 $0
2010-02 0 $0 7,993 $19,433 0 $0
2010-01 0 $0 7,325 $19,374 10,000 $6,000
2009-12 0 $0 1,533 $4,077 0 $0
2009-11 0 $0 2,045 $4,110 28,863 $17,317
2009-10 0 $0 2,049 $4,108 228,751 $137,250
2009-09 0 $0 1,315 $3,642 0 $0
2009-08 0 $0 882 $3,677 0 $0
2009-07 0 $0 925 $3,653 0 $0
2009-06 0 $0 1,170 $3,580 0 $0
2009-05 0 $0 1,170 $3,657 0 $0
2008-12 0 $0 0 $0 33,883 $7,962
2008-11 3,000 $9,825 0 $0 0 $0
2008-04 0 $0 0 $0 71,249 $42,749
2008-03 37,500 $233,365 0 $0 0 $0
2008-02 0 $0 0 $0 57,284 $21,551
2008-01 0 $0 0 $0 20,694 $4,863
2007-12 0 $0 0 $0 10,000 $6,000
2007-11 0 $0 0 $0 10,000 $6,000
2007-09 0 $0 10,000 $130,000 0 $0
2007-08 0 $0 12,000 $137,652 14,000 $116,480
2007-02 0 $0 20,000 $281,100 20,000 $4,700
2007-01 0 $0 26,900 $376,600 0 $0
2006-12 0 $0 0 $0 8,500 $1,997
2006-11 0 $0 253,133 $2,869,786 249,858 $291,678
2006-10 0 $0 5,000 $49,750 0 $0
2006-03 0 $0 5,000 $47,450 0 $0
2006-02 0 $0 54,365 $489,440 0 $0
2005-06 0 $0 15,000 $92,250 0 $0
2005-03 1,315 $9,823 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Array Biopharma Inc insiders (ARRY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-04 Sandor Victor (Chief Medical Officer) Sale 100,000 28.51 2,851,000
2019-06-04 Sandor Victor (Chief Medical Officer) Option Ex 100,000 7.30 730,000
2019-06-03 Sandor Victor (Chief Medical Officer) Sale 36,134 27.59 996,756
2019-06-03 Sandor Victor (Chief Medical Officer) Option Ex 36,134 3.65 131,889
2019-05-30 Sandor Victor (Chief Medical Officer) Sale 15,728 27.50 432,520
2019-05-30 Sandor Victor (Chief Medical Officer) Option Ex 15,728 3.65 57,407
2019-05-28 Sandor Victor (Chief Medical Officer) Sale 74,915 27.00 2,022,929
2019-05-28 Sandor Victor (Chief Medical Officer) Option Ex 46,766 3.65 170,695
2019-05-23 Sandor Victor (Chief Medical Officer) Sale 40,634 26.50 1,076,841
2019-05-23 Sandor Victor (Chief Medical Officer) Option Ex 40,634 3.65 148,314
2019-05-21 Sandor Victor (Chief Medical Officer) Sale 12,600 26.50 333,900
2019-05-21 Sandor Victor (Chief Medical Officer) Option Ex 12,600 3.65 45,990
2019-04-01 Sandor Victor (Chief Medical Officer) Option Ex 15,626 .00 0
2019-04-01 Saccomano Nicholas A (CSO) Option Ex 13,750 .00 0
2019-04-01 Robbins Andrew R (COO) Option Ex 19,688 .00 0
2019-04-01 Squarer Ron (CEO) Option Ex 37,813 .00 0
2019-02-19 Cox Carrie Smith Buy 5,000 23.20 116,000
2019-02-07 Haddock Jason (CFO) Sale 85,000 22.05 1,874,334
2019-02-07 Haddock Jason (CFO) Option Ex 85,000 3.77 320,450
2019-02-07 Saccomano Nicholas A (CSO) Sale 187,264 21.58 4,041,718
2019-02-07 Saccomano Nicholas A (CSO) Option Ex 187,264 3.60 674,150
2019-02-07 Squarer Ron (CEO) Sale 110,000 21.64 2,380,070
2019-02-07 Squarer Ron (CEO) Option Ex 110,000 3.61 397,100
2019-02-06 Haddock Jason (CFO) Sale 11,712 20.00 234,240
2019-02-06 Robbins Andrew R (COO) Sale 239,626 20.02 4,798,510
2019-02-06 Robbins Andrew R (COO) Option Ex 125,000 6.42 801,875
2019-02-06 Lefkoff Kyle Sale 35,000 20.73 725,480
2019-02-06 Lefkoff Kyle Option Ex 25,000 10.47 261,750
2019-02-05 Oltmans Curtis Gale (General Counsel) Sale 40,000 20.00 800,000
2019-02-05 Oltmans Curtis Gale (General Counsel) Option Ex 40,000 8.94 357,600
2019-01-31 Saccomano Nicholas A (CSO) Option Ex 95,236 4.20 399,991
2019-01-31 Squarer Ron (CEO) Sale 113,438 18.53 2,101,552
2019-01-31 Squarer Ron (CEO) Option Ex 113,438 7.30 828,097
2019-01-30 Squarer Ron (CEO) Sale 100,000 18.25 1,825,400
2019-01-30 Squarer Ron (CEO) Option Ex 100,000 3.61 361,000
2019-01-29 Oltmans Curtis Gale (General Counsel) Option Ex 11,100 8.94 99,234
2019-01-25 Oltmans Curtis Gale (General Counsel) Sale 14,029 18.00 252,522
2019-01-25 Oltmans Curtis Gale (General Counsel) Option Ex 14,029 8.94 125,419
2019-01-18 Oltmans Curtis Gale (General Counsel) Sale 1,251 18.00 22,518
2019-01-18 Oltmans Curtis Gale (General Counsel) Option Ex 1,251 8.94 11,183
2019-01-15 Oltmans Curtis Gale (General Counsel) Sale 19,720 18.06 356,143
2019-01-15 Oltmans Curtis Gale (General Counsel) Option Ex 19,720 8.94 176,296
2018-12-27 Sandor Victor (Chief Medical Officer) Sale 6,268 14.05 88,090
2018-12-16 Oltmans Curtis Gale (General Counsel) Option Ex 7,000 .00 0
2018-12-16 Haddock Jason (CFO) Option Ex 11,387 .00 0
2018-12-16 Sandor Victor (Chief Medical Officer) Option Ex 23,346 .00 0
2018-12-16 Saccomano Nicholas A (CSO) Option Ex 12,469 .00 0
2018-12-16 Robbins Andrew R (COO) Option Ex 27,051 .00 0
2018-12-16 Squarer Ron (CEO) Option Ex 48,437 .00 0
2018-12-03 Sandor Victor (Chief Medical Officer) Sale 115,185 16.21 1,867,033
2018-12-03 Sandor Victor (Chief Medical Officer) Option Ex 127,397 3.65 464,999
2018-11-01 Cox Carrie Smith Buy 3,000 16.86 50,594
2018-10-26 Baum Charles M Option Ex 5,000 .00 0
2018-10-26 Fyfe Gwen A. Option Ex 5,000 .00 0
2018-10-26 Orwin John A Option Ex 5,000 .00 0
2018-10-26 Sharp Shalini Option Ex 5,000 .00 0
2018-10-26 Van Lunsen Gil J Option Ex 5,000 .00 0
2018-10-26 Lefkoff Kyle Option Ex 5,000 .00 0
2018-09-19 Van Lunsen Gil J Sale 18,000 14.76 265,680
2018-09-19 Van Lunsen Gil J Option Ex 18,000 5.95 107,100
2018-09-04 Sandor Victor (Chief Medical Officer) Sale 9,687 15.38 148,937
2018-08-15 Haddock Jason (CFO) Sale 20,000 13.92 278,400
2018-08-15 Van Lunsen Gil J Sale 21,500 13.92 299,280
2018-08-15 Van Lunsen Gil J Option Ex 21,500 5.78 124,162
2018-07-30 Haddock Jason (CFO) Sale 25,000 14.87 371,750
2018-07-30 Haddock Jason (CFO) Option Ex 51,525 3.77 194,249
2018-07-18 Van Lunsen Gil J Sale 21,500 16.56 356,040
2018-07-18 Van Lunsen Gil J Option Ex 21,500 5.37 115,347
2018-07-06 Lefkoff Kyle (Director) Sale 50,000 17.45 872,500
2018-07-06 Lefkoff Kyle (Director) Option Ex 50,000 5.54 277,000
2018-06-27 Sandor Victor (Chief Medical Officer) Option Ex 17,440 .00 0
2018-06-27 Saccomano Nicholas A (CSO) Option Ex 11,453 .00 0
2018-06-27 Robbins Andrew R (COO) Sale 17,964 17.74 318,681
2018-06-27 Robbins Andrew R (COO) Option Ex 32,068 .00 0
2018-06-27 Squarer Ron (CEO) Sale 184,253 17.89 3,295,364
2018-06-27 Squarer Ron (CEO) Option Ex 218,506 4.39 960,333
2018-06-20 Van Lunsen Gil J Sale 21,500 19.08 410,219
2018-06-20 Van Lunsen Gil J Option Ex 21,500 4.75 102,017
2018-06-19 Sandor Victor (Chief Medical Officer) Sale 77,576 18.76 1,455,325
2018-06-19 Sandor Victor (Chief Medical Officer) Option Ex 77,576 3.65 283,152
2018-06-13 Sandor Victor (Chief Medical Officer) Sale 22,424 18.75 420,450
2018-06-13 Sandor Victor (Chief Medical Officer) Option Ex 22,424 3.65 81,847
2018-05-16 Van Lunsen Gil J (Director) Sale 21,500 15.36 330,261
2018-05-16 Van Lunsen Gil J (Director) Option Ex 21,500 4.12 88,472
2018-04-18 Van Lunsen Gil J Sale 21,500 15.19 326,585
2018-04-18 Van Lunsen Gil J Option Ex 21,500 3.69 79,335
2018-04-03 Sandor Victor (Chief Medical Officer) Sale 8,689 15.35 133,376
2018-04-01 Sandor Victor (Chief Medical Officer) Option Ex 7,812 .00 0
2018-04-01 Saccomano Nicholas A (CSO) Option Ex 6,875 .00 0
2018-04-01 Robbins Andrew R (COO) Option Ex 9,844 .00 0
2018-04-01 Squarer Ron (CEO) Option Ex 18,906 .00 0
2018-03-21 Van Lunsen Gil J Sale 21,500 16.76 360,340
2018-03-21 Van Lunsen Gil J Option Ex 21,500 3.44 73,960
2018-03-09 Sandor Victor (Chief Medical Officer) Sale 156,016 17.71 2,763,043
2018-03-09 Sandor Victor (Chief Medical Officer) Option Ex 182,191 3.65 664,997
2018-02-21 Van Lunsen Gil J Sale 21,500 17.16 368,940
2018-02-21 Van Lunsen Gil J Option Ex 21,500 2.92 62,672
2018-02-09 Baum Charles M Sale 50,000 16.90 844,999
2018-02-09 Baum Charles M Option Ex 50,000 5.54 277,000
2018-02-09 Lefkoff Kyle Sale 50,000 17.01 850,500
2018-02-09 Lefkoff Kyle Option Ex 50,000 4.74 236,750
2018-01-17 Van Lunsen Gil J Sale 21,500 12.94 278,210
2018-01-17 Van Lunsen Gil J Option Ex 21,500 2.10 45,150
2018-01-16 Haddock Jason (CFO) Sale 7,500 13.73 102,975
2018-01-16 Haddock Jason (CFO) Option Ex 14,025 3.77 52,874
2017-12-19 Squarer Ron (CEO) Sale 546,233 10.93 5,970,326
2017-12-19 Squarer Ron (CEO) Option Ex 546,233 4.73 2,582,043
2017-12-18 Robbins Andrew R (COO) Sale 282,874 10.72 3,032,409
2017-12-18 Robbins Andrew R (COO) Option Ex 397,500 4.90 1,946,954
2017-12-18 Squarer Ron (CEO) Sale 273,438 10.73 2,933,989
2017-12-18 Squarer Ron (CEO) Option Ex 354,509 5.62 1,991,277
2017-12-16 Haddock Jason (CFO) Option Ex 4,387 .00 0
2017-12-16 Sandor Victor (Chief Medical Officer) Option Ex 11,284 8.79 99,186
2017-12-16 Saccomano Nicholas A (CSO) Option Ex 5,468 .00 0
2017-12-16 Robbins Andrew R (COO) Option Ex 13,082 .00 0
2017-12-16 Squarer Ron (CEO) Option Ex 23,437 .00 0
2017-10-27 Baum Charles M Option Ex 5,000 10.47 52,350
2017-10-27 Fyfe Gwen A. Option Ex 5,000 10.47 52,350
2017-10-27 Orwin John A Option Ex 5,000 10.47 52,350
2017-10-27 Van Lunsen Gil J Option Ex 5,000 10.47 52,350
2017-10-27 Lefkoff Kyle Option Ex 5,000 10.47 52,350
2017-09-29 Van Lunsen Gil J Sale 39,928 12.36 493,510
2017-09-29 Van Lunsen Gil J Option Ex 45,000 10.58 476,100
2017-09-29 Lefkoff Kyle Sale 38,865 12.31 478,428
2017-09-29 Lefkoff Kyle Option Ex 45,000 10.58 476,100
2017-08-14 Haddock Jason (CFO) Option Ex 20,000 3.77 75,400
2017-04-01 Sandor Victor (Chief Medical Officer) Option Ex 7,812 .00 0
2017-04-01 Saccomano Nicholas A (CSO) Option Ex 6,875 .00 0
2017-04-01 Robbins Andrew R (COO) Option Ex 9,843 .00 0
2017-04-01 Squarer Ron (CEO) Option Ex 18,906 .00 0
2017-04-01 Moore John R (VP, General Counsel) Option Ex 6,718 .00 0
2017-03-31 Lefkoff Kyle Sale 45,000 8.92 401,400
2017-03-31 Lefkoff Kyle Option Ex 45,000 4.03 181,125
2017-03-28 Baum Charles M Sale 25,000 9.27 231,750
2017-03-28 Baum Charles M Option Ex 25,000 3.87 96,750
2016-10-29 Baum Charles M Option Ex 5,000 5.83 29,150
2016-10-29 Fyfe Gwen A. Option Ex 5,000 5.83 29,150
2016-10-29 Orwin John A Option Ex 5,000 5.83 29,150
2016-10-29 Van Lunsen Gil J Option Ex 5,000 5.83 29,150
2016-10-29 Lefkoff Kyle Option Ex 5,000 5.83 29,150
2016-09-28 Green Jeremy Sale 2,492,578 6.36 15,852,796
2016-09-22 Sandor Victor (Chief Medical Officer) Option Ex 95,890 3.69 353,834
2016-09-15 Green Jeremy Buy 28,000 3.50 98,000
2016-09-15 Green Jeremy Sale 7,300 3.54 25,842
2016-09-14 Green Jeremy Buy 372,000 3.51 1,305,720
2016-09-14 Green Jeremy Sale 392,700 3.50 1,374,450
2016-01-20 Green Jeremy Buy 300,000 3.19 957,000
2016-01-12 Green Jeremy Buy 75,000 3.60 270,000
2016-01-11 Green Jeremy Buy 275,000 3.54 973,500
2016-01-08 Green Jeremy Buy 350,000 3.72 1,302,000
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ARRY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Array Biopharma Inc (symbol ARRY, CIK number 1100412) see the Securities and Exchange Commission (SEC) website.